State Street Corp Raises Stock Holdings in Intuitive Surgical, Inc. $ISRG

State Street Corp raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 15,552,203 shares of the medical equipment provider’s stock after purchasing an additional 182,871 shares during the quarter. State Street Corp’s holdings in Intuitive Surgical were worth $8,451,223,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Tobam raised its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical during the 2nd quarter valued at about $27,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at $1,772,480. This trade represents a 81.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. The trade was a 37.81% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 108,939 shares of company stock valued at $60,757,995. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $566.89 on Tuesday. The firm’s 50-day moving average price is $521.15 and its 200-day moving average price is $505.21. The company has a market capitalization of $203.22 billion, a PE ratio of 74.99, a P/E/G ratio of 5.29 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the company posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on ISRG shares. Rothschild & Co Redburn lifted their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Finally, The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $607.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.